Idiopathic Guttate Hypomelanosis: A Review of its Etiology, Pathogenesis, Findings, and Treatments.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or original human trial data
PubMed 27206417 · doi:10.1007/s40257-016-0195-3
What was done
This narrative review synthesized literature on idiopathic guttate hypomelanosis (IGH), covering its etiology, proposed pathogenic mechanisms, clinical presentations, histologic, dermoscopic, and ultrastructural features, as well as evaluated medical and surgical treatment options.
What was found
The abstract reports no numerical data or quantitative outcomes. It describes IGH as an acquired leukoderma presenting with discrete porcelain-white macules on sun-exposed extremities primarily in individuals over 40 years of age. Proposed contributing factors include aging, ultraviolet radiation, trauma, genetics, autoimmunity, and local inhibition of melanogenesis. Various medical and surgical modalities—including topical retinoids, calcineurin inhibitors, intralesional corticosteroids, cryotherapy, phenol peeling, superficial dermabrasion, grafting, and lasers—have been tested with mixed results, leaving no standard therapy.
Why it matters
This review compiles the etiology, diagnostic features, and varied treatment approaches for a common cosmetic condition lacking standardized therapeutic guidelines.
Limits
The abstract provides no quantitative data, effect sizes, sample size, or systematic search methodology. Findings represent a narrative overview rather than direct trial evidence.
Cited by
- contradicts The small white spots that appear on human skin around age 40 to 50 are areas where the immune system wiped out precancerous or early cancerous melanocytes.